Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.
from RSS Feeds : RSS Feed - NDTV Gadgets360.com https://ift.tt/2XjoJ5n
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment